echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > New 'molecular tool' to trigger targeted immune responses

    New 'molecular tool' to trigger targeted immune responses

    • Last Update: 2022-08-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    A team from the University of Oklahoma has published a study in the journal Advanced Science that proposes a new way to trigger an adaptive immune response


    The research was led by Handan Acar, Ph.


    How cell death provokes an immune response

    It may sound violent, but cell death is an important biological process


    "Injury to the cell membrane can be accidental, due to physical forces, such as cuts or burns, or due to viral or bacterial programming, and this damage can lead to the release of DAMPs," Acar said


    There are two types of immune responses, innate and adaptive


    Acar's team wanted to know how to stress the cells enough to release damage signals that trigger a dialogue between the innate and adaptive immune responses, teaching the immune cells to behave similarly to what happens during vaccination


    Developing a mechanical tool to trigger an immune response

    The research team applied the methodological framework proposed in the previous study to create molecules that can integrate into cells, aggregate and put enough pressure on their membranes to release signals that recruit immune cells to their location


    By making a molecule that can trigger immunogenic cell death and control a small subset of pathogens, they're stimulating a process that teaches the immune system how to respond to a specific bacteria or pathogen, which the researchers believe has therapeutic applications.


    When testing the process with a protein from the flu virus, the researchers found a 15-fold increase in protective and therapeutic antibodies, which can tag infected cells to clear immune cells, 75 days after one injection and one booster injection


    "As engineers, we give doctors and clinical scientists the tools to create treatments, improve diagnosis or improve patient care," Acar said.


    Now, the research team is seeking to better understand the application of this process in the fight against melanoma, pancreatic and breast cancer cells, hoping that the simulated responses suggest that there may be multiple ways their approach could lead to positive results


    Peptide Aggregation Induced Immunogenic Rupture (PAIIR)

    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.